Logo image of WAT

WATERS CORP (WAT) Stock Fundamental Analysis

USA - NYSE:WAT - US9418481035 - Common Stock

371.69 USD
+0.53 (+0.14%)
Last: 11/7/2025, 8:26:11 PM
371.69 USD
0 (0%)
After Hours: 11/7/2025, 8:26:11 PM
Fundamental Rating

6

Taking everything into account, WAT scores 6 out of 10 in our fundamental rating. WAT was compared to 58 industry peers in the Life Sciences Tools & Services industry. WAT gets an excellent profitability rating and is at the same time showing great financial health properties. WAT has a decent growth rate and is not valued too expensively. This makes WAT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

WAT had positive earnings in the past year.
In the past year WAT had a positive cash flow from operations.
WAT had positive earnings in each of the past 5 years.
WAT had a positive operating cash flow in each of the past 5 years.
WAT Yearly Net Income VS EBIT VS OCF VS FCFWAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of WAT (14.02%) is better than 93.10% of its industry peers.
With an excellent Return On Equity value of 30.62%, WAT belongs to the best of the industry, outperforming 94.83% of the companies in the same industry.
WAT's Return On Invested Capital of 19.59% is amongst the best of the industry. WAT outperforms 94.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for WAT is significantly above the industry average of 13.50%.
Industry RankSector Rank
ROA 14.02%
ROE 30.62%
ROIC 19.59%
ROA(3y)16.49%
ROA(5y)18.04%
ROE(3y)77%
ROE(5y)128.85%
ROIC(3y)22.94%
ROIC(5y)25.43%
WAT Yearly ROA, ROE, ROICWAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

The Profit Margin of WAT (21.71%) is better than 96.55% of its industry peers.
WAT's Profit Margin has declined in the last couple of years.
WAT has a better Operating Margin (27.73%) than 96.55% of its industry peers.
In the last couple of years the Operating Margin of WAT has remained more or less at the same level.
WAT's Gross Margin of 59.02% is fine compared to the rest of the industry. WAT outperforms 75.86% of its industry peers.
In the last couple of years the Gross Margin of WAT has remained more or less at the same level.
Industry RankSector Rank
OM 27.73%
PM (TTM) 21.71%
GM 59.02%
OM growth 3Y-1.6%
OM growth 5Y-0.88%
PM growth 3Y-4.65%
PM growth 5Y-2.61%
GM growth 3Y0.51%
GM growth 5Y0.43%
WAT Yearly Profit, Operating, Gross MarginsWAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so WAT is creating value.
The number of shares outstanding for WAT has been increased compared to 1 year ago.
The number of shares outstanding for WAT has been reduced compared to 5 years ago.
The debt/assets ratio for WAT has been reduced compared to a year ago.
WAT Yearly Shares OutstandingWAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
WAT Yearly Total Debt VS Total AssetsWAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 9.60 indicates that WAT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.60, WAT belongs to the best of the industry, outperforming 91.38% of the companies in the same industry.
WAT has a debt to FCF ratio of 2.35. This is a good value and a sign of high solvency as WAT would need 2.35 years to pay back of all of its debts.
WAT has a better Debt to FCF ratio (2.35) than 84.48% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that WAT is somewhat dependend on debt financing.
WAT's Debt to Equity ratio of 0.55 is on the low side compared to the rest of the industry. WAT is outperformed by 65.52% of its industry peers.
Even though the debt/equity ratio score it not favorable for WAT, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.35
Altman-Z 9.6
ROIC/WACC1.88
WACC10.41%
WAT Yearly LT Debt VS Equity VS FCFWAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.75 indicates that WAT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.75, WAT is doing worse than 60.34% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that WAT should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.22, WAT is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
WAT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.22
WAT Yearly Current Assets VS Current LiabilitesWAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

WAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.50%, which is quite good.
The Earnings Per Share has been growing slightly by 5.53% on average over the past years.
WAT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.07%.
The Revenue has been growing slightly by 4.21% on average over the past years.
EPS 1Y (TTM)11.5%
EPS 3Y1.89%
EPS 5Y5.53%
EPS Q2Q%16.04%
Revenue 1Y (TTM)0.07%
Revenue growth 3Y2.02%
Revenue growth 5Y4.21%
Sales Q2Q%8.05%

3.2 Future

The Earnings Per Share is expected to grow by 8.78% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.19% on average over the next years.
EPS Next Y10.52%
EPS Next 2Y10.16%
EPS Next 3Y10.51%
EPS Next 5Y8.78%
Revenue Next Year6.59%
Revenue Next 2Y6.4%
Revenue Next 3Y6.5%
Revenue Next 5Y6.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
WAT Yearly Revenue VS EstimatesWAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
WAT Yearly EPS VS EstimatesWAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.27, the valuation of WAT can be described as expensive.
Based on the Price/Earnings ratio, WAT is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of WAT to the average of the S&P500 Index (25.83), we can say WAT is valued inline with the index average.
With a Price/Forward Earnings ratio of 25.81, WAT can be considered very expensive at the moment.
WAT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. WAT is cheaper than 72.41% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of WAT to the average of the S&P500 Index (32.68), we can say WAT is valued slightly cheaper.
Industry RankSector Rank
PE 29.27
Fwd PE 25.81
WAT Price Earnings VS Forward Price EarningsWAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

WAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. WAT is cheaper than 77.59% of the companies in the same industry.
WAT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WAT is cheaper than 65.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.72
EV/EBITDA 22.25
WAT Per share dataWAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
WAT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.78
PEG (5Y)5.29
EPS Next 2Y10.16%
EPS Next 3Y10.51%

0

5. Dividend

5.1 Amount

WAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WATERS CORP

NYSE:WAT (11/7/2025, 8:26:11 PM)

After market: 371.69 0 (0%)

371.69

+0.53 (+0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-10 2026-02-10/amc
Inst Owners99.31%
Inst Owner Change-0.38%
Ins Owners0.11%
Ins Owner Change0%
Market Cap22.12B
Revenue(TTM)2.96B
Net Income(TTM)661.39M
Analysts72.38
Price Target367.76 (-1.06%)
Short Float %4.01%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.22%
Min EPS beat(2)-0.8%
Max EPS beat(2)0.35%
EPS beat(4)3
Avg EPS beat(4)2.12%
Min EPS beat(4)-0.8%
Max EPS beat(4)8.29%
EPS beat(8)7
Avg EPS beat(8)3.19%
EPS beat(12)10
Avg EPS beat(12)2.57%
EPS beat(16)14
Avg EPS beat(16)4.32%
Revenue beat(2)2
Avg Revenue beat(2)1.03%
Min Revenue beat(2)0.06%
Max Revenue beat(2)2.01%
Revenue beat(4)4
Avg Revenue beat(4)1.42%
Min Revenue beat(4)0.06%
Max Revenue beat(4)2.8%
Revenue beat(8)5
Avg Revenue beat(8)0.26%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)10
Avg Revenue beat(16)0.79%
PT rev (1m)1.33%
PT rev (3m)-6.2%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-0.84%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.5%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 29.27
Fwd PE 25.81
P/S 7.26
P/FCF 35.72
P/OCF 29.68
P/B 10.24
P/tB 91.12
EV/EBITDA 22.25
EPS(TTM)12.7
EY3.42%
EPS(NY)14.4
Fwd EY3.88%
FCF(TTM)10.41
FCFY2.8%
OCF(TTM)12.52
OCFY3.37%
SpS51.18
BVpS36.29
TBVpS4.08
PEG (NY)2.78
PEG (5Y)5.29
Graham Number101.83
Profitability
Industry RankSector Rank
ROA 14.02%
ROE 30.62%
ROCE 22.82%
ROIC 19.59%
ROICexc 21.75%
ROICexgc 51.16%
OM 27.73%
PM (TTM) 21.71%
GM 59.02%
FCFM 20.33%
ROA(3y)16.49%
ROA(5y)18.04%
ROE(3y)77%
ROE(5y)128.85%
ROIC(3y)22.94%
ROIC(5y)25.43%
ROICexc(3y)26.72%
ROICexc(5y)31.12%
ROICexgc(3y)50.26%
ROICexgc(5y)55.59%
ROCE(3y)26.72%
ROCE(5y)29.62%
ROICexgc growth 3Y-9.19%
ROICexgc growth 5Y-5.06%
ROICexc growth 3Y-18.41%
ROICexc growth 5Y-11.04%
OM growth 3Y-1.6%
OM growth 5Y-0.88%
PM growth 3Y-4.65%
PM growth 5Y-2.61%
GM growth 3Y0.51%
GM growth 5Y0.43%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.35
Debt/EBITDA 1.15
Cap/Depr 63.96%
Cap/Sales 4.14%
Interest Coverage 250
Cash Conversion 71.55%
Profit Quality 93.64%
Current Ratio 1.75
Quick Ratio 1.22
Altman-Z 9.6
F-Score5
WACC10.41%
ROIC/WACC1.88
Cap/Depr(3y)103.92%
Cap/Depr(5y)115.41%
Cap/Sales(3y)5.47%
Cap/Sales(5y)5.95%
Profit Quality(3y)75.5%
Profit Quality(5y)85.71%
High Growth Momentum
Growth
EPS 1Y (TTM)11.5%
EPS 3Y1.89%
EPS 5Y5.53%
EPS Q2Q%16.04%
EPS Next Y10.52%
EPS Next 2Y10.16%
EPS Next 3Y10.51%
EPS Next 5Y8.78%
Revenue 1Y (TTM)0.07%
Revenue growth 3Y2.02%
Revenue growth 5Y4.21%
Sales Q2Q%8.05%
Revenue Next Year6.59%
Revenue Next 2Y6.4%
Revenue Next 3Y6.5%
Revenue Next 5Y6.19%
EBIT growth 1Y3.53%
EBIT growth 3Y0.39%
EBIT growth 5Y3.3%
EBIT Next Year23.56%
EBIT Next 3Y15.79%
EBIT Next 5Y10.88%
FCF growth 1Y60.1%
FCF growth 3Y2.29%
FCF growth 5Y5.27%
OCF growth 1Y30.39%
OCF growth 3Y0.66%
OCF growth 5Y3.45%

WATERS CORP / WAT FAQ

Can you provide the ChartMill fundamental rating for WATERS CORP?

ChartMill assigns a fundamental rating of 6 / 10 to WAT.


What is the valuation status of WATERS CORP (WAT) stock?

ChartMill assigns a valuation rating of 4 / 10 to WATERS CORP (WAT). This can be considered as Fairly Valued.


Can you provide the profitability details for WATERS CORP?

WATERS CORP (WAT) has a profitability rating of 8 / 10.


How financially healthy is WATERS CORP?

The financial health rating of WATERS CORP (WAT) is 7 / 10.